The Experts below are selected from a list of 116925 Experts worldwide ranked by ideXlab platform
Kathleen S. Wood - One of the best experts on this subject based on the ideXlab platform.
-
electronic cigarettes as a smoking cessation tool results from an Online Survey
American Journal of Preventive Medicine, 2011Co-Authors: Michael Siegel, Kerry L. Tanwar, Kathleen S. WoodAbstract:Background Electronic cigarettes (e-cigarettes) are battery-powered devices that deliver nicotine without any combustion or smoke. These devices have generated much publicity among the smoking-cessation community and support from dedicated users; however, little is known about the efficacy of the device as a smoking-cessation tool. Purpose This study aimed to examine the effectiveness of e-cigarettes for smoking cessation using a Survey of smokers who had tried e-cigarettes. Methods Using as a sampling frame a cohort of all first-time purchasers of a particular brand of e-cigarettes during a 2-week period, a cross-sectional, Online Survey was conducted in 2010 to describe e-cigarette use patterns and their effectiveness as a smoking-cessation tool. There were 222 respondents, with a Survey response rate of 4.5%. The primary outcome variable was the point prevalence of smoking abstinence at 6 months after initial e-cigarette purchase. Results The primary finding was that the 6-month point prevalence of smoking abstinence among the e-cigarette users in the sample was 31.0% (95% CI=24.8%, 37.2%). A large percentage of respondents reported a reduction in the number of cigarettes they smoked (66.8%) and almost half reported abstinence from smoking for a period of time (48.8%). Those respondents using e-cigarettes more than 20 times per day had a quit rate of 70.0%. Of respondents who were not smoking at 6 months, 34.3% were not using e-cigarettes or any nicotine-containing products at the time. Conclusions Findings suggest that e-cigarettes may hold promise as a smoking-cessation method and that they are worthy of further study using more-rigorous research designs.
-
Electronic cigarettes as a smoking-cessation tool: Results from an Online Survey
American Journal of Preventive Medicine, 2011Co-Authors: Michael B. Siegel, Kerry L. Tanwar, Kathleen S. WoodAbstract:Background: Electronic cigarettes (e-cigarettes) are battery-powered devices that deliver nicotine without any combustion or smoke. These devices have generated much publicity among the smoking-cessation community and support from dedicated users; however, little is known about the efficacy of the device as a smoking-cessation tool. Purpose: This study aimed to examine the effectiveness of e-cigarettes for smoking cessation using a Survey of smokers who had tried e-cigarettes. Methods: Using as a sampling frame a cohort of all first-time purchasers of a particular brand of e-cigarettes during a 2-week period, a cross-sectional, Online Survey was conducted in 2010 to describe e-cigarette use patterns and their effectiveness as a smoking-cessation tool. There were 222 respondents, with a Survey response rate of 4.5%. The primary outcome variable was the point prevalence of smoking abstinence at 6 months after initial e-cigarette purchase. Results: The primary finding was that the 6-month point prevalence of smoking abstinence among the e-cigarette users in the sample was 31.0% (95% CI=24.8%, 37.2%). A large percentage of respondents reported a reduction in the number of cigarettes they smoked (66.8%) and almost half reported abstinence from smoking for a period of time (48.8%). Those respondents using e-cigarettes more than 20 times per day had a quit rate of 70.0%. Of respondents who were not smoking at 6 months, 34.3% were not using e-cigarettes or any nicotine-containing products at the time. Conclusions: Findings suggest that e-cigarettes may hold promise as a smoking-cessation method and that they are worthy of further study using more-rigorous research designs. © 2011 American Journal of Preventive Medicine.
Kerry L. Tanwar - One of the best experts on this subject based on the ideXlab platform.
-
electronic cigarettes as a smoking cessation tool results from an Online Survey
American Journal of Preventive Medicine, 2011Co-Authors: Michael Siegel, Kerry L. Tanwar, Kathleen S. WoodAbstract:Background Electronic cigarettes (e-cigarettes) are battery-powered devices that deliver nicotine without any combustion or smoke. These devices have generated much publicity among the smoking-cessation community and support from dedicated users; however, little is known about the efficacy of the device as a smoking-cessation tool. Purpose This study aimed to examine the effectiveness of e-cigarettes for smoking cessation using a Survey of smokers who had tried e-cigarettes. Methods Using as a sampling frame a cohort of all first-time purchasers of a particular brand of e-cigarettes during a 2-week period, a cross-sectional, Online Survey was conducted in 2010 to describe e-cigarette use patterns and their effectiveness as a smoking-cessation tool. There were 222 respondents, with a Survey response rate of 4.5%. The primary outcome variable was the point prevalence of smoking abstinence at 6 months after initial e-cigarette purchase. Results The primary finding was that the 6-month point prevalence of smoking abstinence among the e-cigarette users in the sample was 31.0% (95% CI=24.8%, 37.2%). A large percentage of respondents reported a reduction in the number of cigarettes they smoked (66.8%) and almost half reported abstinence from smoking for a period of time (48.8%). Those respondents using e-cigarettes more than 20 times per day had a quit rate of 70.0%. Of respondents who were not smoking at 6 months, 34.3% were not using e-cigarettes or any nicotine-containing products at the time. Conclusions Findings suggest that e-cigarettes may hold promise as a smoking-cessation method and that they are worthy of further study using more-rigorous research designs.
-
Electronic cigarettes as a smoking-cessation tool: Results from an Online Survey
American Journal of Preventive Medicine, 2011Co-Authors: Michael B. Siegel, Kerry L. Tanwar, Kathleen S. WoodAbstract:Background: Electronic cigarettes (e-cigarettes) are battery-powered devices that deliver nicotine without any combustion or smoke. These devices have generated much publicity among the smoking-cessation community and support from dedicated users; however, little is known about the efficacy of the device as a smoking-cessation tool. Purpose: This study aimed to examine the effectiveness of e-cigarettes for smoking cessation using a Survey of smokers who had tried e-cigarettes. Methods: Using as a sampling frame a cohort of all first-time purchasers of a particular brand of e-cigarettes during a 2-week period, a cross-sectional, Online Survey was conducted in 2010 to describe e-cigarette use patterns and their effectiveness as a smoking-cessation tool. There were 222 respondents, with a Survey response rate of 4.5%. The primary outcome variable was the point prevalence of smoking abstinence at 6 months after initial e-cigarette purchase. Results: The primary finding was that the 6-month point prevalence of smoking abstinence among the e-cigarette users in the sample was 31.0% (95% CI=24.8%, 37.2%). A large percentage of respondents reported a reduction in the number of cigarettes they smoked (66.8%) and almost half reported abstinence from smoking for a period of time (48.8%). Those respondents using e-cigarettes more than 20 times per day had a quit rate of 70.0%. Of respondents who were not smoking at 6 months, 34.3% were not using e-cigarettes or any nicotine-containing products at the time. Conclusions: Findings suggest that e-cigarettes may hold promise as a smoking-cessation method and that they are worthy of further study using more-rigorous research designs. © 2011 American Journal of Preventive Medicine.
Michael Siegel - One of the best experts on this subject based on the ideXlab platform.
-
electronic cigarettes as a smoking cessation tool results from an Online Survey
American Journal of Preventive Medicine, 2011Co-Authors: Michael Siegel, Kerry L. Tanwar, Kathleen S. WoodAbstract:Background Electronic cigarettes (e-cigarettes) are battery-powered devices that deliver nicotine without any combustion or smoke. These devices have generated much publicity among the smoking-cessation community and support from dedicated users; however, little is known about the efficacy of the device as a smoking-cessation tool. Purpose This study aimed to examine the effectiveness of e-cigarettes for smoking cessation using a Survey of smokers who had tried e-cigarettes. Methods Using as a sampling frame a cohort of all first-time purchasers of a particular brand of e-cigarettes during a 2-week period, a cross-sectional, Online Survey was conducted in 2010 to describe e-cigarette use patterns and their effectiveness as a smoking-cessation tool. There were 222 respondents, with a Survey response rate of 4.5%. The primary outcome variable was the point prevalence of smoking abstinence at 6 months after initial e-cigarette purchase. Results The primary finding was that the 6-month point prevalence of smoking abstinence among the e-cigarette users in the sample was 31.0% (95% CI=24.8%, 37.2%). A large percentage of respondents reported a reduction in the number of cigarettes they smoked (66.8%) and almost half reported abstinence from smoking for a period of time (48.8%). Those respondents using e-cigarettes more than 20 times per day had a quit rate of 70.0%. Of respondents who were not smoking at 6 months, 34.3% were not using e-cigarettes or any nicotine-containing products at the time. Conclusions Findings suggest that e-cigarettes may hold promise as a smoking-cessation method and that they are worthy of further study using more-rigorous research designs.
Michael B. Siegel - One of the best experts on this subject based on the ideXlab platform.
-
Electronic cigarettes as a smoking-cessation tool: Results from an Online Survey
American Journal of Preventive Medicine, 2011Co-Authors: Michael B. Siegel, Kerry L. Tanwar, Kathleen S. WoodAbstract:Background: Electronic cigarettes (e-cigarettes) are battery-powered devices that deliver nicotine without any combustion or smoke. These devices have generated much publicity among the smoking-cessation community and support from dedicated users; however, little is known about the efficacy of the device as a smoking-cessation tool. Purpose: This study aimed to examine the effectiveness of e-cigarettes for smoking cessation using a Survey of smokers who had tried e-cigarettes. Methods: Using as a sampling frame a cohort of all first-time purchasers of a particular brand of e-cigarettes during a 2-week period, a cross-sectional, Online Survey was conducted in 2010 to describe e-cigarette use patterns and their effectiveness as a smoking-cessation tool. There were 222 respondents, with a Survey response rate of 4.5%. The primary outcome variable was the point prevalence of smoking abstinence at 6 months after initial e-cigarette purchase. Results: The primary finding was that the 6-month point prevalence of smoking abstinence among the e-cigarette users in the sample was 31.0% (95% CI=24.8%, 37.2%). A large percentage of respondents reported a reduction in the number of cigarettes they smoked (66.8%) and almost half reported abstinence from smoking for a period of time (48.8%). Those respondents using e-cigarettes more than 20 times per day had a quit rate of 70.0%. Of respondents who were not smoking at 6 months, 34.3% were not using e-cigarettes or any nicotine-containing products at the time. Conclusions: Findings suggest that e-cigarettes may hold promise as a smoking-cessation method and that they are worthy of further study using more-rigorous research designs. © 2011 American Journal of Preventive Medicine.
Matthew W. Johnson - One of the best experts on this subject based on the ideXlab platform.
-
An Online Survey of tobacco smoking cessation associated with naturalistic psychedelic use
Journal of Psychopharmacology, 2017Co-Authors: Matthew W. Johnson, Albert P. Garcia-romeu, Patrick S. Johnson, Roland R. GriffithsAbstract:Data suggest psychedelics such as psilocybin and lysergic acid diethylamide (LSD) may hold therapeutic potential in the treatment of addictions, including tobacco dependence. This retrospective cross-sectional anonymous Online Survey characterized 358 individuals (52 females) who reported having quit or reduced smoking after ingesting a psychedelic in a non-laboratory setting ⩾1 year ago. On average, participants smoked 14 cigarettes/day for 8 years, and had five previous quit attempts before their psychedelic experience. Of the 358 participants, 38% reported continuous smoking cessation after psychedelic use (quitters). Among quitters, 74% reported >2 years’ abstinence. Of the 358 participants, 28% reported a persisting reduction in smoking (reducers), from a mode of 300 cigarettes/month before, to a mode of 1 cigarette/month after the experience. Among reducers, 62% reported >2 years of reduced smoking. Finally, 34% of the 358 participants (relapsers) reported a temporary smoking reduction before return...
-
Psychedelic-associated addiction remission: An Online Survey
Drug and Alcohol Dependence, 2017Co-Authors: Albert P. Garcia-romeu, Roland R. Griffiths, Matthew W. JohnsonAbstract:Aims: To examine instances in which psychedelic use may have led to reduced drug use. Methods: An anonymous Online Survey assessed demographics, drug use history, addiction/withdrawal severity, and data on participants' psychedelic-occasioned experience and perceived effects on substance use. Results: Participants (N= 301) were predominantly White (87%), males (67%), in the US (60%), mean age 32 yrs. Participants reported reductions in alcohol (53% of participants), cannabis (19%), opioid (17%), and stimulant (11%) use after taking a psychedelic. 61% reported continuous substance use reduction lasting >=1 yr. since their reference psychedelic experience. Psilocybin (37%) and LSD (34%) were most commonly associated with reduced substance use. 90% of participants met DSM 5 criteria for a substance use disorder (SUD) before their reference psychedelic experience, with 64% having a severe SUD. Afterward, 19% met criteria for a SUD, with 4% meeting severe SUD criteria. 159 reported reduced alcohol use from a mode of 5-6 drinks on >=4 days/week to a mode of 1-2 drinks/month, with 21% (n = 34) reporting total alcohol abstinence since their psychedelic use. 57 reported reduced cannabis use from a mode of 1-2 uses on >=4 days/week to a mode of 1-2 uses/month, with 21% (n = 12) reporting total cannabis abstinence since their psychedelic use. 51 reported opioid reduction from a mode of 1-2 uses on >=4 days/week to a mode of total opioid abstinence (n = 33; 65%) since their psychedelic use. 34 reported stimulant reduction from a mode of 1-4 uses on >=4 days/week to a mode of total stimulant abstinence (n = 20; 59%) since their psychedelic use. Conclusions: Psychedelic use may sometimes lead to persisting reductions in alcohol and drug use, consistent with prior research suggesting efficacy of psychedelic-facilitated addiction treatment. Further controlled research in this area is indicated.
-
Psychedelic-facilitated smoking cessation: An Online Survey
Drug and Alcohol Dependence, 2015Co-Authors: Albert P. Garcia-romeu, Roland R. Griffiths, Matthew W. JohnsonAbstract:Aims: Pilot laboratory results suggest psilocybin may be an efficacious adjunct to smoking cessation treatment. However, no study has examined smoking cessation after psychedelic use in naturalistic settings. Methods: We are conducting an Online Survey collecting demographics, smoking history, and other data from people who self-report quitting/reducing smoking after taking a psychedelic. Results: Among current completers (N= 164), LSD (49%) and psilocybin (32%) were the drugs most commonly associated with quitting/reducing, with a mode of 2-5 lifetime uses each. Participants reported smoking a mean of 12 cigs/day for a mean of 8 yrs before the experience. 62 (38%) reported total and continuing abstinence after their experience, with 29 of the 62 (47%) reporting >1 yr abstinence, and 7 (11%) reporting >10 yrs abstinence. Another 67 of the 164 (41%) reported persisting smoking reduction, from a mode of 10-20 cigs/day before, to a mode of 1 yr reduction. Although the majority of withdrawal symptoms were rated as equal in severity to previous quit attempts, depression, irritability, anxiety, and craving were rated as "much less severe." 141 of the 164 (86%) reported no premeditated intention to quit/reduce smoking, and 159 (97%) described their experience as highly meaningful, with 97 (59%) considering it among the 10 most meaningful experiences of their lives. Participants cited changed life priorities/values (26%), strengthened belief in their ability to quit (26%), and changed future orientation (17%) as the most important effects leading to quitting/reducing. Other changes reported after psychedelic use included reduced alcohol (38%) and other drug use (23%). Conclusions: Psychedelics may prompt temporary or prolonged smoking cessation, suggesting that careful administration in a treatment context may enhance motivation in changing addictive behaviors. Psychological and neurobiological mechanisms underlying such behavioral changes require further investigation.
